
Darnell A. Pouncil
Examiner (ID: 23, Phone: (571)270-3509 , Office: P/3621 )
| Most Active Art Unit | 3621 |
| Art Unit(s) | 3621, 3688, 3622 |
| Total Applications | 453 |
| Issued Applications | 90 |
| Pending Applications | 53 |
| Abandoned Applications | 316 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6589477
[patent_doc_number] => 20100291627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'METHOD FOR PRODUCTION OF ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 12/734094
[patent_app_country] => US
[patent_app_date] => 2008-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9286
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291627.pdf
[firstpage_image] =>[orig_patent_app_number] => 12734094
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/734094 | Method for production of antibody | Oct 13, 2008 | Issued |
Array
(
[id] => 11928586
[patent_doc_number] => 09795565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant'
[patent_app_type] => utility
[patent_app_number] => 12/739389
[patent_app_country] => US
[patent_app_date] => 2008-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6799
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739389
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/739389 | Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant | Oct 5, 2008 | Issued |
Array
(
[id] => 5379735
[patent_doc_number] => 20090191574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Methods, Products and Treatments for Diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/244851
[patent_app_country] => US
[patent_app_date] => 2008-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10365
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191574.pdf
[firstpage_image] =>[orig_patent_app_number] => 12244851
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/244851 | Methods, products and treatments for diabetes | Oct 2, 2008 | Issued |
Array
(
[id] => 6623559
[patent_doc_number] => 20100324469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'DRUG PRODUCT, A METHOD OF ADMINISTRATING A VACCINE USING THE DRUG PRODUCT, AND AN APPARATUS FOR IONTOPHORESIS'
[patent_app_type] => utility
[patent_app_number] => 12/681508
[patent_app_country] => US
[patent_app_date] => 2008-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7814
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20100324469.pdf
[firstpage_image] =>[orig_patent_app_number] => 12681508
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681508 | DRUG PRODUCT, A METHOD OF ADMINISTRATING A VACCINE USING THE DRUG PRODUCT, AND AN APPARATUS FOR IONTOPHORESIS | Oct 2, 2008 | Abandoned |
Array
(
[id] => 8675002
[patent_doc_number] => 08383114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-26
[patent_title] => 'Pharmaceutical formulations'
[patent_app_type] => utility
[patent_app_number] => 12/680128
[patent_app_country] => US
[patent_app_date] => 2008-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16878
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12680128
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680128 | Pharmaceutical formulations | Sep 28, 2008 | Issued |
Array
(
[id] => 5284457
[patent_doc_number] => 20090098132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'COMPOSITION AND METHOD FOR TREATING LUPUS NEPHRITIS'
[patent_app_type] => utility
[patent_app_number] => 12/235674
[patent_app_country] => US
[patent_app_date] => 2008-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23193
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20090098132.pdf
[firstpage_image] =>[orig_patent_app_number] => 12235674
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/235674 | COMPOSITION AND METHOD FOR TREATING LUPUS NEPHRITIS | Sep 22, 2008 | Abandoned |
Array
(
[id] => 5391196
[patent_doc_number] => 20090208509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Pharmaceutical formulation of an antibody against IL-1R'
[patent_app_type] => utility
[patent_app_number] => 12/284098
[patent_app_country] => US
[patent_app_date] => 2008-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6570
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208509.pdf
[firstpage_image] =>[orig_patent_app_number] => 12284098
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/284098 | Pharmaceutical formulation of an antibody against IL-1R | Sep 17, 2008 | Abandoned |
Array
(
[id] => 5272471
[patent_doc_number] => 20090076247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'HIGH PRESSURE REFOLDING OF MONOCLONAL ANTIBODY AGGREGATES'
[patent_app_type] => utility
[patent_app_number] => 12/208193
[patent_app_country] => US
[patent_app_date] => 2008-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11684
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076247.pdf
[firstpage_image] =>[orig_patent_app_number] => 12208193
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/208193 | HIGH PRESSURE REFOLDING OF MONOCLONAL ANTIBODY AGGREGATES | Sep 9, 2008 | Abandoned |
Array
(
[id] => 6507055
[patent_doc_number] => 20100210567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'USE OF A TUFTSIN AS A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/677311
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33848
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210567.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677311
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677311 | USE OF A TUFTSIN AS A THERAPEUTIC AGENT | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6477273
[patent_doc_number] => 20100285042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'METHODS OF ENHANCING ADJUVATICITY OF VACCINE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/675595
[patent_app_country] => US
[patent_app_date] => 2008-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7556
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12675595
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/675595 | Methods of enhancing adjuvaticity of vaccine compositions | Aug 27, 2008 | Issued |
Array
(
[id] => 5315531
[patent_doc_number] => 20090280129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/197005
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 32111
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280129.pdf
[firstpage_image] =>[orig_patent_app_number] => 12197005
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/197005 | HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS | Aug 21, 2008 | Abandoned |
Array
(
[id] => 9073925
[patent_doc_number] => 08551501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-08
[patent_title] => 'Chitin microparticles and their medical uses'
[patent_app_type] => utility
[patent_app_number] => 12/195479
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11384
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12195479
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195479 | Chitin microparticles and their medical uses | Aug 20, 2008 | Issued |
Array
(
[id] => 6540665
[patent_doc_number] => 20100204444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'MULTIFUNCTIONAL PROTEIN SIMULTANEOUSLY DELIVERING ANTIBODIES AND NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/670245
[patent_app_country] => US
[patent_app_date] => 2008-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3010
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204444.pdf
[firstpage_image] =>[orig_patent_app_number] => 12670245
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670245 | MULTIFUNCTIONAL PROTEIN SIMULTANEOUSLY DELIVERING ANTIBODIES AND NANOPARTICLES | Jul 24, 2008 | Abandoned |
Array
(
[id] => 5928980
[patent_doc_number] => 20110038939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'THERAPEUTIC STABLE NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/669395
[patent_app_country] => US
[patent_app_date] => 2008-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12386
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20110038939.pdf
[firstpage_image] =>[orig_patent_app_number] => 12669395
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669395 | THERAPEUTIC STABLE NANOPARTICLES | Jul 15, 2008 | Abandoned |
Array
(
[id] => 5290075
[patent_doc_number] => 20090022805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Polypeptide microparticles having sustained release characteristics, methods and uses'
[patent_app_type] => utility
[patent_app_number] => 12/215508
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 32474
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022805.pdf
[firstpage_image] =>[orig_patent_app_number] => 12215508
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/215508 | Polypeptide microparticles having sustained release characteristics, methods and uses | Jun 26, 2008 | Abandoned |
Array
(
[id] => 5569373
[patent_doc_number] => 20090252751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'Immune adjuvant comprising ubiquinone'
[patent_app_type] => utility
[patent_app_number] => 12/213947
[patent_app_country] => US
[patent_app_date] => 2008-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4804
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20090252751.pdf
[firstpage_image] =>[orig_patent_app_number] => 12213947
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/213947 | Immune adjuvant comprising ubiquinone | Jun 25, 2008 | Abandoned |
Array
(
[id] => 9503289
[patent_doc_number] => 08741600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Method for separation of immunoglobulin monomers'
[patent_app_type] => utility
[patent_app_number] => 12/665651
[patent_app_country] => US
[patent_app_date] => 2008-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 60504
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665651
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665651 | Method for separation of immunoglobulin monomers | Jun 17, 2008 | Issued |
Array
(
[id] => 6595794
[patent_doc_number] => 20100292092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'ANTIBODY FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/664777
[patent_app_country] => US
[patent_app_date] => 2008-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5820
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292092.pdf
[firstpage_image] =>[orig_patent_app_number] => 12664777
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/664777 | ANTIBODY FORMULATIONS | Jun 12, 2008 | Abandoned |
Array
(
[id] => 5391179
[patent_doc_number] => 20090208492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Lyophilized Immunoglobulin Formulations and Methods of Preparation'
[patent_app_type] => utility
[patent_app_number] => 12/138075
[patent_app_country] => US
[patent_app_date] => 2008-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 41831
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208492.pdf
[firstpage_image] =>[orig_patent_app_number] => 12138075
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/138075 | Lyophilized Immunoglobulin Formulations and Methods of Preparation | Jun 11, 2008 | Abandoned |
Array
(
[id] => 4720321
[patent_doc_number] => 20080242844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Ultra-high Yield Intravenous Immune Globulin Preparation'
[patent_app_type] => utility
[patent_app_number] => 12/134504
[patent_app_country] => US
[patent_app_date] => 2008-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9408
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242844.pdf
[firstpage_image] =>[orig_patent_app_number] => 12134504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/134504 | Ultra-high Yield Intravenous Immune Globulin Preparation | Jun 5, 2008 | Abandoned |